pandemic Archives -

In the final piece of a three-part series, Ben Hargreaves explores how manufacturing infrastructure was rapidly built up

Preventing the next pandemic: Infrastructure and global equity

https://pharmaphorum.com/r-d/preventing-the-next-pandemic-infrastructure-and-global-equity/

R&D/ Views & Analysis/ Views and analysis

Preventing the next pandemic: Supporting early-stage R&D

Ben Hargreaves AstraZenca, COVID-19, GSK, pandemic, preventing the next pandemic 0 Comment

In the second of a three-part series, Ben Hargreaves looks at the importance of early-stage research into various

Preventing the next pandemic: Supporting early-stage R&D

https://pharmaphorum.com/r-d/preventing-the-next-pandemic-supporting-early-stage-rd/

Market Access/ Views & Analysis/ Views and analysis

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

mike.hammerton@pharmaphorum.com COVID-19, IQVIA, launch excellence, pandemic, Sarah Rickwood 0 Comment

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. COVID

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

https://pharmaphorum.com/market-access-2/pharmas-post-pandemic-launch-performance-problem/

R&D/ Views & Analysis/ Views and analysis

Preventing the next pandemic: Learning the lessons

Ben Hargreaves covid, covid19, pandemic, pharma, preventing the next pandemic, WHO 0 Comment

In the first of a three-part series, Ben Hargreaves looks at what the odds are of another pandemic

Preventing the next pandemic: Learning the lessons

https://pharmaphorum.com/r-d/preventing-the-next-pandemic-learning-the-lessons/

Patients/ Views & Analysis/ Views and analysis

From healthcare to human care: Shaping a healthier society

mike.hammerton@pharmaphorum.com COVID-19, mental health, pandemic, patients 0 Comment

Janssen’s Roz Bekker, VP Commercial Strategy for Infectious Diseases & Vaccines at Janssen EMEA, looks at how COVID-19

From healthcare to human care: Shaping a healthier society

https://pharmaphorum.com/patients/janssen-from-healthcare-to-human-care-shaping-healthier-society/

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

Surprise pandemic lessons for pharma

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Oncology, IQVIA, Oncology, pandemic, SARS 0 Comment

Ask people in most western nations to think back to 2019 and consider what they would have said

Surprise pandemic lessons for pharma

https://pharmaphorum.com/views-analysis-oncology/surprise-pandemic-lessons-for-pharma/

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

Oncology and a year of COVID: lessons for the future

mike.hammerton@pharmaphorum.com covid, Deep Dive, Deep Dive: Oncology, Frances O’Connor, Lucid, Lucid Group, Oncology, pandemic 0 Comment

COVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up

Oncology and a year of COVID: lessons for the future

https://pharmaphorum.com/views-analysis-oncology/oncology-and-a-year-of-covid-lessons-for-the-future/

Deep Dive/ Market Access/ Views & Analysis/ Views and analysis

A year on: pandemic driven trends in HCP engagement

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Market Access, HCP, IQVIA, market access, pandemic 0 Comment

IQVIA’s John Procter explores why the industry should be paying attention to the changing HCP customer experience in

A year on: pandemic driven trends in HCP engagement

https://pharmaphorum.com/views-analysis-market-access/pandemic-driven-trends-hcp-engagement/

Digital/ Views & Analysis/ Views and analysis

Could a smartphone cough app stop future pandemics?

Richard Staines COVID-19, digital, infectious diseases, influenza, pandemic, tuberculosis 0 Comment

A host of companies are looking at cough apps to detect the presence of COVID-19. But one company

Could a smartphone cough app stop future pandemics?

https://pharmaphorum.com/views-and-analysis/could-a-cough-app-stop-future-pandemics/

Trending

pandemic

Login